Review



human ace2 pe conjugated antibody  (Bio-Techne corporation)


Bioz Verified Symbol Bio-Techne corporation is a verified supplier
Bioz Manufacturer Symbol Bio-Techne corporation manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    Bio-Techne corporation human ace2 pe conjugated antibody
    Spike pseudotyped lentiviral particles infect <t>A549-hACE2</t> cells. Spike D614 (a) and delta B-1.6172 (b) pseudotyped GFP lentiviral particles infect 2 × 104 A549-hACE2 cells. GFP: Green fluorecent protien
    Human Ace2 Pe Conjugated Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human ace2 pe conjugated antibody/product/Bio-Techne corporation
    Average 94 stars, based on 2 article reviews
    human ace2 pe conjugated antibody - by Bioz Stars, 2026-03
    94/100 stars

    Images

    1) Product Images from "Preventive treatment of coronavirus disease-2019 virus using coronavirus disease-2019-receptor-binding domain 1C aptamer by suppress the expression of angiotensin-converting enzyme 2 receptor"

    Article Title: Preventive treatment of coronavirus disease-2019 virus using coronavirus disease-2019-receptor-binding domain 1C aptamer by suppress the expression of angiotensin-converting enzyme 2 receptor

    Journal: Journal of Advanced Pharmaceutical Technology & Research

    doi: 10.4103/JAPTR.JAPTR_117_23

    Spike pseudotyped lentiviral particles infect A549-hACE2 cells. Spike D614 (a) and delta B-1.6172 (b) pseudotyped GFP lentiviral particles infect 2 × 104 A549-hACE2 cells. GFP: Green fluorecent protien
    Figure Legend Snippet: Spike pseudotyped lentiviral particles infect A549-hACE2 cells. Spike D614 (a) and delta B-1.6172 (b) pseudotyped GFP lentiviral particles infect 2 × 104 A549-hACE2 cells. GFP: Green fluorecent protien

    Techniques Used:

    Dose–response curves of the CoV-2-RBD-1C aptamer’s IC 50 . 0.05, 0.15, 0.32, 0.75, 1.56, 3.12, 6.25, 12.5, 25, 50, and 100 μM dose concentrations of CoV-2-RBD-1C aptamer were applied to A549-hACE2 cells for 72 h. Through the use of nonlinear regression analysis, IC 50 values were calculated (Prism Pad 8.1). Results are based on the triplicate of the data, IC 50 : Half-maximum inhibitory concentration, CoV-2-RBD-1C: Coronavirus-2-receptor-binding domain 1C, CoV-2-RBD-1C: Coronavirus-2-receptor-binding domain 1C
    Figure Legend Snippet: Dose–response curves of the CoV-2-RBD-1C aptamer’s IC 50 . 0.05, 0.15, 0.32, 0.75, 1.56, 3.12, 6.25, 12.5, 25, 50, and 100 μM dose concentrations of CoV-2-RBD-1C aptamer were applied to A549-hACE2 cells for 72 h. Through the use of nonlinear regression analysis, IC 50 values were calculated (Prism Pad 8.1). Results are based on the triplicate of the data, IC 50 : Half-maximum inhibitory concentration, CoV-2-RBD-1C: Coronavirus-2-receptor-binding domain 1C, CoV-2-RBD-1C: Coronavirus-2-receptor-binding domain 1C

    Techniques Used: Concentration Assay, Binding Assay

    CoV-2-RBD-1C aptamer effect son SARS-CoV-2-Spike-ACE2 inhibition. The ELISA method was used to measure the binding inhibition. Bars refer to mean ± SD. Distilled water is the solvent control; * P < 0.05. One-way ANOVA was used to determine the difference’s significance with the solvent control. SARS-CoV-2: Severe acute respiratory syndrome coronavirus-2, ACE2: Angiotensin-converting enzyme 2, SD: Standard deviation, CoV-2-RBD-1C: Coronavirus-2-receptor-binding domain 1C
    Figure Legend Snippet: CoV-2-RBD-1C aptamer effect son SARS-CoV-2-Spike-ACE2 inhibition. The ELISA method was used to measure the binding inhibition. Bars refer to mean ± SD. Distilled water is the solvent control; * P < 0.05. One-way ANOVA was used to determine the difference’s significance with the solvent control. SARS-CoV-2: Severe acute respiratory syndrome coronavirus-2, ACE2: Angiotensin-converting enzyme 2, SD: Standard deviation, CoV-2-RBD-1C: Coronavirus-2-receptor-binding domain 1C

    Techniques Used: Inhibition, Enzyme-linked Immunosorbent Assay, Binding Assay, Solvent, Standard Deviation

    Preincubation with the aptamer CoV-2-RBD-1C prevents the spike D614 binding and its variants N501Y and D614G to human A549-hACE2 cells. One-way ANOVA was employed to evaluate the significant variations in contrast to the related solvent control. * P < 0.05; bars represent mean ± SD. SD: Standard deviation, CoV-2-RBD-1C: Coronavirus-2-receptor-binding domain 1C
    Figure Legend Snippet: Preincubation with the aptamer CoV-2-RBD-1C prevents the spike D614 binding and its variants N501Y and D614G to human A549-hACE2 cells. One-way ANOVA was employed to evaluate the significant variations in contrast to the related solvent control. * P < 0.05; bars represent mean ± SD. SD: Standard deviation, CoV-2-RBD-1C: Coronavirus-2-receptor-binding domain 1C

    Techniques Used: Binding Assay, Solvent, Standard Deviation

    The ability of viruses to transduce A549-hACE2 cells was inhibited by the CoV-2-RBD-1C aptamer. * P < 0.05; n more than or equal to 3 independent tests. One-way ANOVA was employed to evaluate the significance of the difference with the solvent control. CoV-2-RBD-1C: Coronavirus-2-receptor-binding domain 1C
    Figure Legend Snippet: The ability of viruses to transduce A549-hACE2 cells was inhibited by the CoV-2-RBD-1C aptamer. * P < 0.05; n more than or equal to 3 independent tests. One-way ANOVA was employed to evaluate the significance of the difference with the solvent control. CoV-2-RBD-1C: Coronavirus-2-receptor-binding domain 1C

    Techniques Used: Transduction, Solvent, Binding Assay

    Ability of viruses to transduce A549-hACE2 cells was inhibited by the CoV-2-RBD-1C aptamer. (a) Before being infected with the SARS-CoV-2 spike Delta B-1-617-2 variants 7500 TU/mL for 24 h. * P < 0.05; n more than or equal to 3 independent tests. one-way ANOVA was used to evaluate the significance of the difference in relation to the solvent control. SARS-CoV-2: Severe acute respiratory syndrome coronavirus-2, CoV-2-RBD-1C: Coronavirus-2-receptor-binding domain 1C
    Figure Legend Snippet: Ability of viruses to transduce A549-hACE2 cells was inhibited by the CoV-2-RBD-1C aptamer. (a) Before being infected with the SARS-CoV-2 spike Delta B-1-617-2 variants 7500 TU/mL for 24 h. * P < 0.05; n more than or equal to 3 independent tests. one-way ANOVA was used to evaluate the significance of the difference in relation to the solvent control. SARS-CoV-2: Severe acute respiratory syndrome coronavirus-2, CoV-2-RBD-1C: Coronavirus-2-receptor-binding domain 1C

    Techniques Used: Transduction, Infection, Solvent, Binding Assay



    Similar Products

    ace2 goat anti hace2  (R&D Systems)
    93
    R&D Systems ace2 goat anti hace2
    Ace2 Goat Anti Hace2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ace2 goat anti hace2/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    ace2 goat anti hace2 - by Bioz Stars, 2026-03
    93/100 stars
    		  Buy from Supplier
    human ace2 pe conjugated antibody  (Bio-Techne corporation)
    94
    Bio-Techne corporation human ace2 pe conjugated antibody
    Spike pseudotyped lentiviral particles infect <t>A549-hACE2</t> cells. Spike D614 (a) and delta B-1.6172 (b) pseudotyped GFP lentiviral particles infect 2 × 104 A549-hACE2 cells. GFP: Green fluorecent protien
    Human Ace2 Pe Conjugated Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human ace2 pe conjugated antibody/product/Bio-Techne corporation
    Average 94 stars, based on 1 article reviews
    human ace2 pe conjugated antibody - by Bioz Stars, 2026-03
    94/100 stars
    		  Buy from Supplier
    polyclonal goat anti human ace2 antibody  (R&D Systems)
    94
    R&D Systems polyclonal goat anti human ace2 antibody
    Spike pseudotyped lentiviral particles infect <t>A549-hACE2</t> cells. Spike D614 (a) and delta B-1.6172 (b) pseudotyped GFP lentiviral particles infect 2 × 104 A549-hACE2 cells. GFP: Green fluorecent protien
    Polyclonal Goat Anti Human Ace2 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/polyclonal goat anti human ace2 antibody/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    polyclonal goat anti human ace2 antibody - by Bioz Stars, 2026-03
    94/100 stars
    		  Buy from Supplier
    primary goat anti human ace2 antibody  (R&D Systems)
    93
    R&D Systems primary goat anti human ace2 antibody
    Spike pseudotyped lentiviral particles infect <t>A549-hACE2</t> cells. Spike D614 (a) and delta B-1.6172 (b) pseudotyped GFP lentiviral particles infect 2 × 104 A549-hACE2 cells. GFP: Green fluorecent protien
    Primary Goat Anti Human Ace2 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary goat anti human ace2 antibody/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    primary goat anti human ace2 antibody - by Bioz Stars, 2026-03
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    Spike pseudotyped lentiviral particles infect A549-hACE2 cells. Spike D614 (a) and delta B-1.6172 (b) pseudotyped GFP lentiviral particles infect 2 × 104 A549-hACE2 cells. GFP: Green fluorecent protien

    Journal: Journal of Advanced Pharmaceutical Technology & Research

    Article Title: Preventive treatment of coronavirus disease-2019 virus using coronavirus disease-2019-receptor-binding domain 1C aptamer by suppress the expression of angiotensin-converting enzyme 2 receptor

    doi: 10.4103/JAPTR.JAPTR_117_23

    Figure Lengend Snippet: Spike pseudotyped lentiviral particles infect A549-hACE2 cells. Spike D614 (a) and delta B-1.6172 (b) pseudotyped GFP lentiviral particles infect 2 × 104 A549-hACE2 cells. GFP: Green fluorecent protien

    Article Snippet: Flow cytometric analysis and a human ACE2 PE-conjugated antibody (Human ACE2 PE-conjugated antibodies, Wiesbaden-Nordenstadt, BioTechne GmbH, Germany) were employed to determine the amount of ACE2 that is expressed on the surface of the cells in accordance with the procedure provided by the manufacturers.

    Techniques:

    Dose–response curves of the CoV-2-RBD-1C aptamer’s IC 50 . 0.05, 0.15, 0.32, 0.75, 1.56, 3.12, 6.25, 12.5, 25, 50, and 100 μM dose concentrations of CoV-2-RBD-1C aptamer were applied to A549-hACE2 cells for 72 h. Through the use of nonlinear regression analysis, IC 50 values were calculated (Prism Pad 8.1). Results are based on the triplicate of the data, IC 50 : Half-maximum inhibitory concentration, CoV-2-RBD-1C: Coronavirus-2-receptor-binding domain 1C, CoV-2-RBD-1C: Coronavirus-2-receptor-binding domain 1C

    Journal: Journal of Advanced Pharmaceutical Technology & Research

    Article Title: Preventive treatment of coronavirus disease-2019 virus using coronavirus disease-2019-receptor-binding domain 1C aptamer by suppress the expression of angiotensin-converting enzyme 2 receptor

    doi: 10.4103/JAPTR.JAPTR_117_23

    Figure Lengend Snippet: Dose–response curves of the CoV-2-RBD-1C aptamer’s IC 50 . 0.05, 0.15, 0.32, 0.75, 1.56, 3.12, 6.25, 12.5, 25, 50, and 100 μM dose concentrations of CoV-2-RBD-1C aptamer were applied to A549-hACE2 cells for 72 h. Through the use of nonlinear regression analysis, IC 50 values were calculated (Prism Pad 8.1). Results are based on the triplicate of the data, IC 50 : Half-maximum inhibitory concentration, CoV-2-RBD-1C: Coronavirus-2-receptor-binding domain 1C, CoV-2-RBD-1C: Coronavirus-2-receptor-binding domain 1C

    Article Snippet: Flow cytometric analysis and a human ACE2 PE-conjugated antibody (Human ACE2 PE-conjugated antibodies, Wiesbaden-Nordenstadt, BioTechne GmbH, Germany) were employed to determine the amount of ACE2 that is expressed on the surface of the cells in accordance with the procedure provided by the manufacturers.

    Techniques: Concentration Assay, Binding Assay

    CoV-2-RBD-1C aptamer effect son SARS-CoV-2-Spike-ACE2 inhibition. The ELISA method was used to measure the binding inhibition. Bars refer to mean ± SD. Distilled water is the solvent control; * P < 0.05. One-way ANOVA was used to determine the difference’s significance with the solvent control. SARS-CoV-2: Severe acute respiratory syndrome coronavirus-2, ACE2: Angiotensin-converting enzyme 2, SD: Standard deviation, CoV-2-RBD-1C: Coronavirus-2-receptor-binding domain 1C

    Journal: Journal of Advanced Pharmaceutical Technology & Research

    Article Title: Preventive treatment of coronavirus disease-2019 virus using coronavirus disease-2019-receptor-binding domain 1C aptamer by suppress the expression of angiotensin-converting enzyme 2 receptor

    doi: 10.4103/JAPTR.JAPTR_117_23

    Figure Lengend Snippet: CoV-2-RBD-1C aptamer effect son SARS-CoV-2-Spike-ACE2 inhibition. The ELISA method was used to measure the binding inhibition. Bars refer to mean ± SD. Distilled water is the solvent control; * P < 0.05. One-way ANOVA was used to determine the difference’s significance with the solvent control. SARS-CoV-2: Severe acute respiratory syndrome coronavirus-2, ACE2: Angiotensin-converting enzyme 2, SD: Standard deviation, CoV-2-RBD-1C: Coronavirus-2-receptor-binding domain 1C

    Article Snippet: Flow cytometric analysis and a human ACE2 PE-conjugated antibody (Human ACE2 PE-conjugated antibodies, Wiesbaden-Nordenstadt, BioTechne GmbH, Germany) were employed to determine the amount of ACE2 that is expressed on the surface of the cells in accordance with the procedure provided by the manufacturers.

    Techniques: Inhibition, Enzyme-linked Immunosorbent Assay, Binding Assay, Solvent, Standard Deviation

    Preincubation with the aptamer CoV-2-RBD-1C prevents the spike D614 binding and its variants N501Y and D614G to human A549-hACE2 cells. One-way ANOVA was employed to evaluate the significant variations in contrast to the related solvent control. * P < 0.05; bars represent mean ± SD. SD: Standard deviation, CoV-2-RBD-1C: Coronavirus-2-receptor-binding domain 1C

    Journal: Journal of Advanced Pharmaceutical Technology & Research

    Article Title: Preventive treatment of coronavirus disease-2019 virus using coronavirus disease-2019-receptor-binding domain 1C aptamer by suppress the expression of angiotensin-converting enzyme 2 receptor

    doi: 10.4103/JAPTR.JAPTR_117_23

    Figure Lengend Snippet: Preincubation with the aptamer CoV-2-RBD-1C prevents the spike D614 binding and its variants N501Y and D614G to human A549-hACE2 cells. One-way ANOVA was employed to evaluate the significant variations in contrast to the related solvent control. * P < 0.05; bars represent mean ± SD. SD: Standard deviation, CoV-2-RBD-1C: Coronavirus-2-receptor-binding domain 1C

    Article Snippet: Flow cytometric analysis and a human ACE2 PE-conjugated antibody (Human ACE2 PE-conjugated antibodies, Wiesbaden-Nordenstadt, BioTechne GmbH, Germany) were employed to determine the amount of ACE2 that is expressed on the surface of the cells in accordance with the procedure provided by the manufacturers.

    Techniques: Binding Assay, Solvent, Standard Deviation

    The ability of viruses to transduce A549-hACE2 cells was inhibited by the CoV-2-RBD-1C aptamer. * P < 0.05; n more than or equal to 3 independent tests. One-way ANOVA was employed to evaluate the significance of the difference with the solvent control. CoV-2-RBD-1C: Coronavirus-2-receptor-binding domain 1C

    Journal: Journal of Advanced Pharmaceutical Technology & Research

    Article Title: Preventive treatment of coronavirus disease-2019 virus using coronavirus disease-2019-receptor-binding domain 1C aptamer by suppress the expression of angiotensin-converting enzyme 2 receptor

    doi: 10.4103/JAPTR.JAPTR_117_23

    Figure Lengend Snippet: The ability of viruses to transduce A549-hACE2 cells was inhibited by the CoV-2-RBD-1C aptamer. * P < 0.05; n more than or equal to 3 independent tests. One-way ANOVA was employed to evaluate the significance of the difference with the solvent control. CoV-2-RBD-1C: Coronavirus-2-receptor-binding domain 1C

    Article Snippet: Flow cytometric analysis and a human ACE2 PE-conjugated antibody (Human ACE2 PE-conjugated antibodies, Wiesbaden-Nordenstadt, BioTechne GmbH, Germany) were employed to determine the amount of ACE2 that is expressed on the surface of the cells in accordance with the procedure provided by the manufacturers.

    Techniques: Transduction, Solvent, Binding Assay

    Ability of viruses to transduce A549-hACE2 cells was inhibited by the CoV-2-RBD-1C aptamer. (a) Before being infected with the SARS-CoV-2 spike Delta B-1-617-2 variants 7500 TU/mL for 24 h. * P < 0.05; n more than or equal to 3 independent tests. one-way ANOVA was used to evaluate the significance of the difference in relation to the solvent control. SARS-CoV-2: Severe acute respiratory syndrome coronavirus-2, CoV-2-RBD-1C: Coronavirus-2-receptor-binding domain 1C

    Journal: Journal of Advanced Pharmaceutical Technology & Research

    Article Title: Preventive treatment of coronavirus disease-2019 virus using coronavirus disease-2019-receptor-binding domain 1C aptamer by suppress the expression of angiotensin-converting enzyme 2 receptor

    doi: 10.4103/JAPTR.JAPTR_117_23

    Figure Lengend Snippet: Ability of viruses to transduce A549-hACE2 cells was inhibited by the CoV-2-RBD-1C aptamer. (a) Before being infected with the SARS-CoV-2 spike Delta B-1-617-2 variants 7500 TU/mL for 24 h. * P < 0.05; n more than or equal to 3 independent tests. one-way ANOVA was used to evaluate the significance of the difference in relation to the solvent control. SARS-CoV-2: Severe acute respiratory syndrome coronavirus-2, CoV-2-RBD-1C: Coronavirus-2-receptor-binding domain 1C

    Article Snippet: Flow cytometric analysis and a human ACE2 PE-conjugated antibody (Human ACE2 PE-conjugated antibodies, Wiesbaden-Nordenstadt, BioTechne GmbH, Germany) were employed to determine the amount of ACE2 that is expressed on the surface of the cells in accordance with the procedure provided by the manufacturers.

    Techniques: Transduction, Infection, Solvent, Binding Assay